Meet with us and learn about our enzymatic doggybone DNA.
DNA Manufacturing for advanced therapy production
Touchlight DNA Services provide rapid, enzymatic DNA development and manufacturing for all advanced therapy production, including mRNA, non-viral gene therapy, AAV, lentivirus, genome editing and DNA API.
Touchlight’s novel, synthetic DNA vector known as doggybone DNA (dbDNA™), is an antibiotic resistance free DNA vector with fast manufacturing timelines for research through to GMP applications.
dbDNA is a minimal, linear, covalently closed structure, that eliminates bacterial sequences. Touchlight’s revolutionary enzymatic production platform enables unprecedented speed, scale, and the ability to target genes with a size and complexity that is impossible with current technologies.
Clients can be supported from pre-clinical through development and supply, to licencing and tech transfer for use in-house.
How dbDNA can help you.
- Simple and rapid GMP manufacturing
- Improved quality, safety, and reliability
- Avoidance of quality issues caused by complexity of sequence
Learn more about how doggybone DNA is made
Brands: doggybone DNA (dbDNA) enzymatically produced DNA that can improve speed to manufacture, safety and scalability in comparison to plasmid DNA, for mRNA, AAV, DNA API and non-viral gene therapy.